前列腺影像报告和数据系统第2版评估类别与活检确诊Gleason评分3+4=7前列腺癌患者病理结局的关系
研究纳入81例经直肠超声引导活检确诊为Gleason评分3+4=7前列腺癌并接受多参数MRI和根治性前列腺切除术的男性,评估PI-RADSv2类别与术后升级至Gleason评分4+3=7或以上及精囊外侵犯的关联。结果显示PI-RADSv2类别越高,术后升级至4+3=7和精囊外侵犯的风险越高,PI-RADSv2≥3分诊断4+3=7肿瘤的敏感度为100%。
要点
- 活检确诊Gleason评分3+4=7的患者中,PI-RADSv2类别越高,术后升级至4+3=7的风险越高。
- PI-RADSv2≥3分诊断术后Gleason评分4+3=7肿瘤的敏感度为100%。
- 精囊外侵犯存在时PI-RADSv2类别更高;观察者间一致性中等(κ=0.43)。
核心结论
- 对于经直肠超声引导活检确诊的Gleason评分3+4=7前列腺癌,较高的PI-RADSv2评估类别与根治性前列腺切除术后升级至Gleason评分4+3=7以及精囊外侵犯的存在相关;PI-RADSv2评分≥3分诊断Gleason评分4+3=7肿瘤的敏感度为100%。
研究设计与样本
- 研究为2012年至2015年间纳入81例经直肠超声引导活检确诊为Gleason评分3+4=7前列腺癌并接受多参数MRI和根治性前列腺切除术的男性;两名盲法放射科医生使用分区图分配PI-RADSv2评估类别(1-5类),并与根治性前列腺切除术后肿瘤位置、Gleason评分和精囊外侵犯情况进行比较。
关键影像表现/征象
- 根治性前列腺切除术后53.1%(43/81)的男性存在精囊外侵犯,21.0%(17/81)为Gleason评分4+3=7前列腺癌,2.5%(2/81)降级为Gleason评分3+3=6。
- Gleason评分4+3=7肿瘤的PI-RADSv2评估类别显著更高(p=0.03)。
- 存在精囊外侵犯时PI-RADSv2类别更高(p<0.001)。
- 肿瘤定位准确率范围为86.4%至92.6%,88.2%(15/17)的定位错误发生于Gleason评分3+3=6或3+4=7肿瘤(p=0.30)。
诊断标准与关键数值
- PI-RADSv2诊断Gleason评分4+3=7肿瘤的AUC为0.65(95%CI 0.54-0.77)。
- PI-RADSv2类别≥4分诊断Gleason评分4+3=7肿瘤的敏感度为94.1%,特异度为23.4%。
- PI-RADSv2类别<3分的患者中无Gleason评分4+3=7肿瘤;PI-RADSv2评分≥3分诊断Gleason评分4+3=7肿瘤的敏感度为100%。
- 观察者间一致性为中等(κ=0.43)。
临床应用与阅片要点
- 在活检确诊Gleason评分3+4=7的患者中,PI-RADSv2类别较高提示术后可能升级至Gleason评分4+3=7并存在精囊外侵犯。
- PI-RADSv2类别<3分未见Gleason评分4+3=7肿瘤,PI-RADSv2评分≥3分对诊断Gleason评分4+3=7肿瘤的敏感度为100%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to assess associations between Prostate Imaging Reporting and Data System, version 2 (PI-RADSv2), categories and the presence of a tumor with a Gleason score (GS) of 4 + 3 = 7 or greater or the presence of extraprostatic extension (EPE) at radical prostatectomy (RP) in patients with a GS 3 + 4 = 7 tumor at biopsy.
MATERIALS AND METHODS: A total of 81 men with GS 3 + 4 = 7 prostate cancer diagnosed by transrectal ultrasound-guided biopsy underwent multiparametric MRI and RP between 2012 and 2015. Two blinded radiologists assessed multiparametric MR images and assigned PI-RADSv2 assessment categories (categories 1-5) with the use of sector maps, which were compared with regard to the location of the tumor, the GS, and the presence of EPE at RP. Comparisons were performed between groups with the use of chi-square and multivariate analysis. Diagnostic accuracy was assessed using ROC curve analysis, and localization was compared using the Fisher exact test.
RESULTS: A total of 53.1% of men (43/81) had EPE, and 21.0% (17/81) had GS 4 + 3 = 7 prostate cancer after RP, whereas 2.5% of men (2/81) had their tumors downgraded to GS 3 + 3 = 6. No statistically significant difference in patient age, prostate specific antigen level, or clinical stage existed between groups (p > 0.05). PI-RADSv2 assessment categories were significantly higher for GS 4 + 3 = 7 tumors (p = 0.03). PI-RADSv2 showed moderate accuracy for the diagnosis of GS 4 + 3 = 7 tumors (AUC, 0.65; 95% CI, 0.54-0.77), with a category of 4 or higher having a sensitivity and specificity for diagnosis of 94.1% and 23.4%, respectively. No patient with a PI-RADSv2 category lower than 3 had a GS 4 + 3 = 7 tumor. Accuracy of tumor localization ranged from 86.4% to 92.6%, with 88.2% of errors (15/17) occurring in GS 3 + 3 = 6 or GS 3 + 4 = 7 tumors (p = 0.30). PI-RADSv2 categories were noted to be higher when EPE was present (p < 0.001). Interobserver agreement was moderate (κ = 0.43).
CONCLUSION: For GS 3 + 4 = 7 cancers detected at transrectal ultrasound-guided biopsy, higher PI-RADSv2 assessment categories are associated with upgrading to GS 4 + 3 = 7 cancer and with the presence of EPE after RP. A PI-RADSv2 score of 3 or higher was 100% sensitive for diagnosing GS 4 + 3 = 7 tumors.
引用
- Lim CS, McInnes MDF, Flood TA, et al. Prostate Imaging Reporting and Data System, Version 2, Assessment Categories and Pathologic Outcomes in Patients With Gleason Score 3 + 4 = 7 Prostate Cancer Diagnosed at Biopsy. AJR Am J Roentgenol. 2017. PMID: 28267359. doi:10.2214/AJR.16.16843
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。